ArticleBioinformatics advances2026
Cell type annotation using large language models (LLMs) and CytoAnalyst.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Motivation: Cell annotation is fundamental for single-cell data interpretation. Accurate annotation allows us to identify cell types, understand their functions, trace developmental trajectories, and pinpoint alterations associated with a condition of interest. However, this complex process demands extensive manual curation, domain expertise, and proficiency across diverse bioinformatics tools. These challenges impede reproducibility and consistency. Results: We have developed a new approach for semi-automatic cell type annotation, powered by large language models (LLMs). Given the input single-cell data, we first perform dimension reduction, clustering, and differential analysis to identify distinct cell groups and their respective markers. Next, we utilize Meta's Llama and structured prompting to infer potential cell types. This approach greatly reduces manual labor from researchers while maintaining biological accuracy through enforced ontology, tissue context, and marker gene signatures. Our solution is freely accessible through our web-based platform named CytoAnalyst, hosted on a high-performance infrastructure with optimized networking and storage capabilities. CytoAnalyst also offers capabilities for quality control, embedding analysis, clustering, differential analysis, gene set analysis, cell enrichment, cell type annotation, and pseudo-time trajectory inference. Availability and implementation: CytoAnalyst is freely available at https://cytoanalyst.tinnguyen-lab.com/. The CytoAnalyst handbook, including step-by-step tutorials and example case studies, is available at https://cytoanalyst.tinnguyen-lab.com/docs/.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.